{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:26:20Z","timestamp":1787235980275,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["PEPR-EDITO"],"award-info":[{"award-number":["PEPR-EDITO"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["PEPR-THERA-B"],"award-info":[{"award-number":["PEPR-THERA-B"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["PEPR-THERA B"],"award-info":[{"award-number":["PEPR-THERA B"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Caring Cross"},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["Marie Curie Phd Network GET-IN"],"award-info":[{"award-number":["Marie Curie Phd Network GET-IN"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Previously, we confirmed that BaEV-LVs outperformed VSV-G-LVs for gene delivery or correction of human T cells, B cells, NK cells and HSPCs correlating with high expression of its receptors, ASCT-1 and ASCT-2 on these cells. Since HERV-W gp uses the same entry receptors, we compared transduction efficiencies for BaEV-LVs and HERV-W-LVs in hematopoietic cells. HERV-W LV transduction was efficient but inferior to BaEV-LV in TCR-stimulated T cells (40% versus 80%) and this low efficiency was even more pronounced in IL-7\/IL-15 pre-stimulated T cells. BaEV-LVs were significantly superior over HERV-W-LVs for the transduction of B cells and NK cells. High HERV-W-LV mediated transduction levels were achieved for pre-stimulated hCD34+ cells, which remained though lower than for the BaEV-LVs. Additionally, BaEV-LVs reached over 80% of transduction in severe combined immunodeficiency (SCID) repopulating cells (SRC) in 6\/6 engrafted NBSGW mice. HERV-W-LVs reached this transduction level in 1\/5 mice, while 3\/5 engrafted NBSGW mice reached significantly lower transduction levels (20\u201350%). For both vectors the transduction levels were equivalent in the lymphoid and myeloid lineages in all hematopoietic tissues, suggesting transduction of immature HSPCs. Summarizing, BaEV-LVs outperformed HERV-W-LVs for transduction of important gene therapy target cells such as NK, B, T cells and CD34+ HSPCs.<\/jats:p>","DOI":"10.1038\/s41434-025-00587-w","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T18:04:11Z","timestamp":1768845851000},"page":"144-155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Baboon endogenous retrovirus (ERV) envelope pseudotyped lentiviral vectors outperform human ERV lentivectors for transduction of T, B, NK and HSPCs"],"prefix":"10.1038","volume":"33","author":[{"given":"S\u00e9verine","family":"P\u00e9rian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0858-914X","authenticated-orcid":false,"given":"Eva","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Martinello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0153-4392","authenticated-orcid":false,"given":"Anne","family":"Galy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gis\u00e8le","family":"Froment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimas","family":"Orentas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Valeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9224-5491","authenticated-orcid":false,"given":"Els","family":"Verhoeyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"587_CR1","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/35057039","volume":"409","author":"WH Li","year":"2001","unstructured":"Li WH, Gu Z, Wang H, Nekrutenko A. Evolutionary analyses of the human genome. Nature. 2001;409:847\u20139.","journal-title":"Nature"},{"key":"587_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1101\/gr.216902","volume":"12","author":"A Pavl\u00edcek","year":"2002","unstructured":"Pavl\u00edcek A, Paces J, Elleder D, Hejnar J. Processed pseudogenes of human endogenous retroviruses generated by LINEs: their integration, stability, and distribution. Genome Res. 2002;12:391\u20139.","journal-title":"Genome Res"},{"key":"587_CR3","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1128\/JVI.74.7.3321-3329.2000","volume":"74","author":"JL Blond","year":"2000","unstructured":"Blond JL, Lavillette D, Cheynet V, Bouton O, Oriol G, Chapel-Fernandes S, et al. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J Virol. 2000;74:3321\u20139.","journal-title":"J Virol"},{"key":"587_CR4","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1053\/plac.2001.0722","volume":"22","author":"X Lee","year":"2001","unstructured":"Lee X, Keith JC, Stumm N, Moutsatsos I, McCoy JM, Crum CP, et al. Downregulation of placental syncytin expression and abnormal protein localization in pre-eclampsia. Placenta. 2001;22:808\u201312.","journal-title":"Placenta"},{"key":"587_CR5","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1128\/MCB.23.10.3566-3574.2003","volume":"23","author":"J-L Frendo","year":"2003","unstructured":"Frendo J-L, Olivier D, Cheynet V, Blond J-L, Bouton O, Vidaud M, et al. Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation. Mol. Cell Biol. 2003;23:3566\u201374.","journal-title":"Mol. Cell Biol"},{"key":"587_CR6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/35001608","volume":"403","author":"S Mi","year":"2000","unstructured":"Mi S, Lee X, Li X, Veldman GM, Finnerty H, Racie L, et al. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature. 2000;403:785\u20139.","journal-title":"Nature"},{"key":"587_CR7","doi-asserted-by":"publisher","first-page":"7901","DOI":"10.1007\/s11033-023-08658-0","volume":"50","author":"M Gholami Barzoki","year":"2023","unstructured":"Gholami Barzoki M, Shatizadeh Malekshahi S, Heydarifard Z, Mahmodi MJ, Soltanghoraee H. The important biological roles of Syncytin-1 of human endogenous retrovirus W (HERV-W) and Syncytin-2 of HERV-FRD in the human placenta development. Mol Biol Rep. 2023;50:7901\u20137.","journal-title":"Mol Biol Rep"},{"key":"587_CR8","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1073\/pnas.96.5.2129","volume":"96","author":"JE Rasko","year":"1999","unstructured":"Rasko JE, Battini JL, Gottschalk RJ, Mazo I, Miller AD. The RD114\/simian type D retrovirus receptor is a neutral amino acid transporter. Proc Natl Acad Sci USA. 1999;96:2129\u201334.","journal-title":"Proc Natl Acad Sci USA"},{"key":"587_CR9","doi-asserted-by":"publisher","first-page":"4470","DOI":"10.1128\/JVI.73.5.4470-4474.1999","volume":"73","author":"CS Tailor","year":"1999","unstructured":"Tailor CS, Nouri A, Zhao Y, Takeuchi Y, Kabat D. A sodium-dependent neutral-amino-acid transporter mediates infections of feline and baboon endogenous retroviruses and simian type D retroviruses. J Virol. 1999;73:4470\u20134.","journal-title":"J Virol"},{"key":"587_CR10","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1128\/JVI.77.5.2936-2945.2003","volume":"77","author":"M Marin","year":"2003","unstructured":"Marin M, Lavillette D, Kelly SM, Kabat D. N-linked glycosylation and sequence changes in a critical negative control region of the ASCT1 and ASCT2 neutral amino acid transporters determine their retroviral receptor functions. J Virol. 2003;77:2936\u201345.","journal-title":"J Virol"},{"key":"587_CR11","doi-asserted-by":"publisher","first-page":"6442","DOI":"10.1128\/JVI.76.13.6442-6452.2002","volume":"76","author":"D Lavillette","year":"2002","unstructured":"Lavillette D, Marin M, Ruggieri A, Mallet F, Cosset F-L, Kabat D. The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters\/cell surface receptors. J Virol. 2002;76:6442\u201352.","journal-title":"J Virol"},{"key":"587_CR12","doi-asserted-by":"publisher","first-page":"5585","DOI":"10.1128\/JVI.79.9.5585-5593.2005","volume":"79","author":"V Cheynet","year":"2005","unstructured":"Cheynet V, Ruggieri A, Oriol G, Blond J-L, Boson B, Vachot L, et al. Synthesis, assembly, and processing of the Env ERVWE1\/syncytin human endogenous retroviral envelope. J Virol. 2005;79:5585\u201393.","journal-title":"J Virol"},{"key":"587_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.mam.2013.01.001","volume":"34","author":"Y Kanai","year":"2013","unstructured":"Kanai Y, Cl\u00e9men\u00e7on B, Simonin A, Leuenberger M, Lochner M, Weisstanner M, et al. The SLC1 high-affinity glutamate and neutral amino acid transporter family. Mol Asp Med. 2013;34:108\u201320.","journal-title":"Mol Asp Med"},{"key":"587_CR14","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1007\/s11064-019-02934-x","volume":"45","author":"N Freidman","year":"2020","unstructured":"Freidman N, Chen I, Wu Q, Briot C, Holst J, Font J, et al. Amino acid transporters and exchangers from the SLC1A family: structure, mechanism and roles in physiology and cancer. Neurochem Res. 2020;45:1268\u201386.","journal-title":"Neurochem Res"},{"key":"587_CR15","doi-asserted-by":"publisher","first-page":"7306","DOI":"10.1073\/pnas.1214441110","volume":"110","author":"D Finkelshtein","year":"2013","unstructured":"Finkelshtein D, Werman A, Novick D, Barak S, Rubinstein M. LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus. Proc Natl Acad Sci. 2013;110:7306\u201311.","journal-title":"Proc Natl Acad Sci"},{"key":"587_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03432-4","volume":"9","author":"J Nikolic","year":"2018","unstructured":"Nikolic J, Belot L, Raux H, Legrand P, Gaudin Y, Albertini A. Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein. Nat. Commun. 2018;9:1029.","journal-title":"Nat. Commun."},{"key":"587_CR17","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1182\/blood-2013-11-540641","volume":"123","author":"F Amirache","year":"2014","unstructured":"Amirache F, L\u00e9vy C, Costa C, Mangeot P-E, Torbett BE, Wang CX, et al. Mystery solved: VSV-G-LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor. Blood. 2014;123:1422\u20134.","journal-title":"Blood"},{"key":"587_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1182\/bloodadvances.2018027508","volume":"3","author":"O Bernadin","year":"2019","unstructured":"Bernadin O, Amirache F, Girard-Gagnepain A, Moirangthem RD, L\u00e9vy C, Ma K, et al. Baboon envelope LVs efficiently transduced human adult, fetal, and progenitor T cells and corrected SCID-X1 T-cell deficiency. Blood Adv. 2019;3:461\u201375.","journal-title":"Blood Adv"},{"key":"587_CR19","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1182\/blood.V99.7.2342","volume":"99","author":"M Maurice","year":"2002","unstructured":"Maurice M, Verhoeyen E, Salmon P, Trono D, Russell SJ, Cosset F-L. Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell\u2013activating polypeptide. Blood. 2002;99:2342\u201350.","journal-title":"Blood"},{"key":"587_CR20","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.3389\/fimmu.2019.02873","volume":"10","author":"ABL Colamartino","year":"2019","unstructured":"Colamartino ABL, Lemieux W, Bifsha P, Nicoletti S, Chakravarti N, Sanz J, et al. Efficient and robust NK-cell transduction with baboon envelope pseudotyped lentivector. Front Immunol. 2019;10:2873.","journal-title":"Front Immunol"},{"key":"587_CR21","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1111\/jth.13520","volume":"14","author":"C Levy","year":"2016","unstructured":"Levy C, Fusil F, Amirache F, Costa C, Girard-Gagnepain A, Negre D, et al. Baboon envelope pseudotyped lentiviral vectors efficiently transduce human B cells and allow active factor IX B cell secretion in vivo in NOD\/SCID\u03b3c-\/- mice. J Thromb Haemost. 2016;14:2478\u201392.","journal-title":"J Thromb Haemost"},{"key":"587_CR22","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1038\/mt.2015.148","volume":"23","author":"F Fusil","year":"2015","unstructured":"Fusil F, Calattini S, Amirache F, Mancip J, Costa C, Robbins JB, et al. A lentiviral vector allowing physiologically regulated membrane-anchored and secreted antibody expression depending on B-cell maturation status. Mol Ther. 2015;23:1734\u201347.","journal-title":"Mol Ther"},{"key":"587_CR23","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1182\/blood-2001-11-0042","volume":"100","author":"V Sandrin","year":"2002","unstructured":"Sandrin V, Boson B, Salmon P, Gay W, N\u00e8gre D, Le Grand R, et al. Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood. 2002;100:823\u201332.","journal-title":"Blood"},{"key":"587_CR24","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1182\/blood-2014-02-558163","volume":"124","author":"A Girard-Gagnepain","year":"2014","unstructured":"Girard-Gagnepain A, Amirache F, Costa C, L\u00e9vy C, Frecha C, Fusil F, et al. Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs. Blood. 2014;124:1221\u201331.","journal-title":"Blood"},{"key":"587_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.omtm.2017.02.003","volume":"5","author":"C Piovan","year":"2017","unstructured":"Piovan C, Marin V, Scavullo C, Corna S, Giuliani E, Bossi S, et al. Vectofusin-1 promotes RD114-TR-pseudotyped lentiviral vector transduction of human HSPCs and T lymphocytes. Mol Ther Methods Clin Dev. 2017;5:22\u201330.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"587_CR26","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.ymthe.2003.07.002","volume":"8","author":"M Ward","year":"2003","unstructured":"Ward M, Sattler R, Grossman IR, Bell AJ, Skerrett D, Baxi L, et al. A stable murine-based RD114 retroviral packaging line efficiently transduces human hematopoietic cells. Mol Ther. 2003;8:804\u201312.","journal-title":"Mol Ther"},{"key":"587_CR27","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1089\/hum.2019.157","volume":"30","author":"C Radek","year":"2019","unstructured":"Radek C, Bernadin O, Drechsel K, Cordes N, Pfeifer R, Str\u00e4\u00dfer P, et al. Vectofusin-1 improves transduction of primary human cells with diverse retroviral and lentiviral pseudotypes, enabling robust, automated closed-system manufacturing. Hum Gene Ther. 2019;30:1477\u201393.","journal-title":"Hum Gene Ther"},{"key":"587_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.biomaterials.2016.04.019","volume":"97","author":"V Labenski","year":"2016","unstructured":"Labenski V, Suerth JD, Barczak E, Heckl D, Levy C, Bernadin O, et al. Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes. Biomaterials. 2016;97:97\u2013109.","journal-title":"Biomaterials"},{"key":"587_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40164-023-00461-8","volume":"12","author":"Q Ren","year":"2023","unstructured":"Ren Q, Zu Y, Su H, Lu Q, Xiang B, Luo Y, et al. Single VHH-directed BCMA CAR-NK cells for multiple myeloma. Exp Hematol Oncol. 2023;12:98.","journal-title":"Exp Hematol Oncol"},{"key":"587_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1290488","volume":"14","author":"IS Ciulean","year":"2023","unstructured":"Ciulean IS, Fischer J, Quaiser A, Bach C, Abken H, Tretbar US, et al. CD44v6 specific CAR-NK cells for targeted immunotherapy of head and neck squamous cell carcinoma. Front Immunol. 2023;14:1290488.","journal-title":"Front Immunol"},{"key":"587_CR31","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1038\/s41596-021-00510-8","volume":"16","author":"T Weidner","year":"2021","unstructured":"Weidner T, Agarwal S, Perian S, Fusil F, Braun G, Hartmann J, et al. Genetic in vivo engineering of human T lymphocytes in mouse models. Nat Protoc. 2021;16:3210\u201340.","journal-title":"Nat Protoc"},{"key":"587_CR32","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.3389\/fimmu.2019.02001","volume":"10","author":"R Bari","year":"2019","unstructured":"Bari R, Granzin M, Tsang KS, Roy A, Krueger W, Orentas R, et al. A distinct subset of highly proliferative and Lentiviral Vector (LV)-transducible NK cells define a readily engineered subset for adoptive cellular therapy. Front Immunol. 2019;10:2001.","journal-title":"Front Immunol"},{"key":"587_CR33","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","volume":"100","author":"M Ito","year":"2002","unstructured":"Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, et al. NOD\/SCID\/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002;100:3175\u201382.","journal-title":"Blood"},{"key":"587_CR34","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.stemcr.2014.12.005","volume":"4","author":"BE McIntosh","year":"2015","unstructured":"McIntosh BE, Brown ME, Duffin BM, Maufort JP, Vereide DT, Slukvin II, et al. Nonirradiated NOD,B6.SCID Il2r\u03b3-\/- Kit(W41\/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells. Stem Cell Rep. 2015;4:171\u201380.","journal-title":"Stem Cell Rep"},{"key":"587_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.exphem.2016.12.012","volume":"48","author":"PH Miller","year":"2017","unstructured":"Miller PH, Rabu G, MacAldaz M, Knapp DJHF, Cheung AMS, Dhillon K, et al. Analysis of parameters that affect human hematopoietic cell outputs in mutant c-kit-immunodeficient mice. Exp Hematol. 2017;48:41\u201349.","journal-title":"Exp Hematol"},{"key":"587_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2019.113711","volume":"174","author":"C Brendel","year":"2020","unstructured":"Brendel C, Rio P, Verhoeyen E. Humanized mice are precious tools for evaluation of hematopoietic gene therapies and preclinical modeling to move towards a clinical trial. Biochem Pharmacol. 2020;174:113711.","journal-title":"Biochem Pharmacol"},{"key":"587_CR37","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1038\/s41551-024-01240-4","volume":"8","author":"GL Rogers","year":"2024","unstructured":"Rogers GL, Huang C, Mathur A, Huang X, Chen H-Y, Stanten K, et al. Reprogramming human B cells with custom heavy-chain antibodies. Nat Biomed Eng. 2024;8:1700\u201314.","journal-title":"Nat Biomed Eng"},{"key":"587_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03187-1","volume":"11","author":"B Luo","year":"2020","unstructured":"Luo B, Zhan Y, Luo M, Dong H, Liu J, Lin Y, et al. Engineering of \u03b1-PD-1 antibody-expressing long-lived plasma cells by CRISPR\/Cas9-mediated targeted gene integration. Cell Death Dis. 2020;11:973.","journal-title":"Cell Death Dis"},{"key":"587_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19649-1","volume":"11","author":"AD Nahmad","year":"2020","unstructured":"Nahmad AD, Raviv Y, Horovitz-Fried M, Sofer I, Akriv T, Nataf D, et al. Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion. Nat Commun. 2020;11:5851.","journal-title":"Nat Commun"},{"key":"587_CR40","doi-asserted-by":"publisher","unstructured":"Jamil A, Qureshi Z, Siddique R, Altaf F, Jamil R, Wali N. A meta-analysis on effects of chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia. Am. J. Clin. Oncol. https:\/\/doi.org\/10.1097\/COC.0000000000001176 2025.","DOI":"10.1097\/COC.0000000000001176"},{"key":"587_CR41","volume":"16","author":"AT Ibrahiam","year":"2024","unstructured":"Ibrahiam AT, Geddada S, Ullah N, Al-Qassab ZM, Ahmed O, Khan S. Chimeric Antigen Receptor (CAR) T-cell therapy in the treatment of diffuse large B-cell Lymphoma (DLBCL): a systematic review. Cureus. 2024;16:e75854.","journal-title":"Cureus"},{"key":"587_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/cells14010041","volume":"14","author":"M Canichella","year":"2025","unstructured":"Canichella M, de Fabritiis P. CAR-T therapy beyond B-cell hematological malignancies. Cells. 2025;14:41.","journal-title":"Cells"},{"key":"587_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1454747","volume":"15","author":"WH Robinson","year":"2024","unstructured":"Robinson WH, Fiorentino D, Chung L, Moreland LW, Deodhar M, Harler MB, et al. Cutting-edge approaches to B-cell depletion in autoimmune diseases. Front Immunol. 2024;15:1454747.","journal-title":"Front Immunol"},{"key":"587_CR44","doi-asserted-by":"publisher","first-page":"e2024031","DOI":"10.4084\/MJHID.2024.031","volume":"16","author":"U Testa","year":"2024","unstructured":"Testa U, Chiusolo P, Pelosi E, Castelli G, Leone G. CAR-T cell therapy for T-Cell malignancies. Mediterr J Hematol Infect Dis. 2024;16:e2024031.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"587_CR45","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/bjh.17544","volume":"195","author":"K Sanber","year":"2021","unstructured":"Sanber K, Savani B, Jain T. Graft-versus-host disease risk after chimeric antigen receptor T-cell therapy: the diametric opposition of T cells. Br J Haematol. 2021;195:660\u20138.","journal-title":"Br J Haematol"},{"key":"587_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1409665","volume":"15","author":"A Mohammad","year":"2024","unstructured":"Mohammad A, Yurina A, Simonyan T, Chistyakov D, Salman R, Zornikova K, et al. Modular (universal) CAR-T platforms in vivo: a comprehensive systematic review. Front Immunol. 2024;15:1409665.","journal-title":"Front Immunol"},{"key":"587_CR47","doi-asserted-by":"crossref","unstructured":"Carlson S, Lin TL, Larson SM. Allogeneic chimeric antigen receptors (CARs) as an \u2018off-the-shelf\u2019 therapy in multiple myeloma. Immunotherapy 17, 211\u2013222 (2025).","DOI":"10.1080\/1750743X.2025.2461987"},{"key":"587_CR48","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/cancers14010183","volume":"14","author":"A Krug","year":"2021","unstructured":"Krug A, Martinez-Turtos A, Verhoeyen E. Importance of T, NK, CAR T and CAR NK cell metabolic fitness for effective anti-cancer therapy: a continuous learning process allowing the optimization of T, NK and CAR-based anti-cancer therapies. Cancers. 2021;14:183.","journal-title":"Cancers"},{"key":"587_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28762-2","volume":"13","author":"F Tucci","year":"2022","unstructured":"Tucci F, Galimberti S, Naldini L, Valsecchi MG, Aiuti A. A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders. Nat Commun. 2022;13:1315.","journal-title":"Nat Commun"},{"key":"587_CR50","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1089\/hum.2009.001","volume":"20","author":"K Ghani","year":"2009","unstructured":"Ghani K, Wang X, de Campos-Lima PO, Olszewska M, Kamen A, Rivi\u00e8re I, et al. Efficient human hematopoietic cell transduction using RD114- and GALV-pseudotyped retroviral vectors produced in suspension and serum-free media. Hum Gene Ther. 2009;20:966\u201374.","journal-title":"Hum Gene Ther"},{"key":"587_CR51","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1089\/hgtb.2012.160","volume":"23","author":"U Mock","year":"2012","unstructured":"Mock U, Thiele R, Uhde A, Fehse B, Horn S. Efficient lentiviral transduction and transgene expression in primary human B cells. Hum Gene Ther Methods. 2012;23:408\u201315.","journal-title":"Hum Gene Ther Methods"},{"key":"587_CR52","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1182\/blood-2001-12-0249","volume":"101","author":"F Bovia","year":"2003","unstructured":"Bovia F, Salmon P, Matthes T, Kvell K, Nguyen TH, Werner-Favre C, et al. Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors. Blood. 2003;101:1727\u201333.","journal-title":"Blood"},{"key":"587_CR53","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.virol.2004.04.038","volume":"325","author":"M Serafini","year":"2004","unstructured":"Serafini M, Naldini L, Introna M. Molecular evidence of inefficient transduction of proliferating human B lymphocytes by VSV-pseudotyped HIV-1-derived lentivectors. Virology. 2004;325:413\u201324.","journal-title":"Virology"},{"key":"587_CR54","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/gt.2009.11","volume":"16","author":"S Funke","year":"2009","unstructured":"Funke S, Schneider IC, Glaser S, M\u00fchlebach MD, Moritz T, Cattaneo R, et al. Pseudotyping lentiviral vectors with the wild-type measles virus glycoproteins improves titer and selectivity. Gene Ther. 2009;16:700\u20135.","journal-title":"Gene Ther"},{"key":"587_CR55","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1182\/blood-2009-05-220798","volume":"114","author":"C Frecha","year":"2009","unstructured":"Frecha C, Costa C, L\u00e9vy C, N\u00e8gre D, Russell SJ, Maisner A, et al. Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors. Blood. 2009;114:3173\u201380.","journal-title":"Blood"},{"key":"587_CR56","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s13287-021-02462-y","volume":"12","author":"F Marofi","year":"2021","unstructured":"Marofi F, Saleh MM, Rahman HS, Suksatan W, Al-Gazally ME, Abdelbasset WK, et al. CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies. Stem Cell Res Ther. 2021;12:374.","journal-title":"Stem Cell Res Ther"},{"key":"587_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1507","volume":"13","author":"A Pfefferle","year":"2024","unstructured":"Pfefferle A, Contet J, Wong K, Chen C, Verhoeyen E, Slichter CK, et al. Optimisation of a primary human CAR-NK cell manufacturing pipeline. Clin Transl Immunol. 2024;13:e1507.","journal-title":"Clin Transl Immunol"},{"key":"587_CR58","doi-asserted-by":"publisher","first-page":"e004244","DOI":"10.1136\/jitc-2021-004244","volume":"10","author":"P-L Bernard","year":"2022","unstructured":"Bernard P-L, Delconte R, Pastor S, Laletin V, Costa Da Silva C, Goubard A, et al. Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity. J Immunother Cancer. 2022;10:e004244.","journal-title":"J Immunother Cancer"},{"key":"587_CR59","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.3389\/fimmu.2019.03123","volume":"10","author":"S M\u00fcller","year":"2019","unstructured":"M\u00fcller S, Bexte T, Gebel V, Kalensee F, Stolzenberg E, Hartmann J, et al. High cytotoxic efficiency of lentivirally and alpharetrovirally engineered cd19-specific chimeric antigen receptor natural killer cells against acute lymphoblastic leukemia. Front Immunol. 2019;10:3123.","journal-title":"Front Immunol"},{"key":"587_CR60","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/leu.2016.372","volume":"31","author":"C Costa","year":"2017","unstructured":"Costa C, Hypolite G, Bernadin O, L\u00e9vy C, Cosset F-L, Asnafi V, et al. Baboon envelope pseudotyped lentiviral vectors: a highly efficient new tool to genetically manipulate T-cell acute lymphoblastic leukaemia-initiating cells. Leukemia. 2017;31:977\u201380.","journal-title":"Leukemia"},{"key":"587_CR61","doi-asserted-by":"crossref","unstructured":"\u0160tafl K, Tr\u00e1vn\u00ed\u010dek M, Janovsk\u00e1 A, Ku\u010derov\u00e1 D, Pecnov\u00e1 \u013d, Yang Z, et al. Receptor usage of Syncytin-1: ASCT2, but not ASCT1, is a functional receptor and effector of cell fusion in the human placenta. Proc Natl Acad Sci USA. 2024;121:e2407519121.","DOI":"10.1073\/pnas.2407519121"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00587-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00587-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00587-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:05:35Z","timestamp":1775574335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00587-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["587"],"URL":"https:\/\/doi.org\/10.1038\/s41434-025-00587-w","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EV is inventor on the patent on pseudotyping of retroviral particles with BaEV envelope glycoproteins (patent WO 07290918.7)","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"NBSGW mice were housed in our animal facility (Plateau de Biologie Exp\u00e9rimentale de la Souris (PBES), Lyon, France). Experiments were performed in accordance with the European Union guidelines upon approval of the protocols by the local ethical committee. (Autorization agreement N\u00b0 C2EA -15: CECCAPP, Lyon, France). Umbilical cord blood (CB) samples from full-term pregnancies and peripheral blood samples were obtained from healthy donors after informed consent (provided by EFS, Besan\u00e7on, France) and approval was obtained by the ethical committee of the hospital according to the Helsinki declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}